[Rifampicin--application and side-effects]. 1970

T Midtvedt

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012293 Rifampin A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) Rifampicin,Benemycin,Rifadin,Rimactan,Rimactane,Tubocin

Related Publications

T Midtvedt
July 1983, Leprosy in India,
T Midtvedt
October 1971, British medical journal,
T Midtvedt
September 1978, Die Medizinische Welt,
T Midtvedt
January 1972, British medical journal,
T Midtvedt
January 1973, Scandinavian journal of respiratory diseases. Supplementum,
T Midtvedt
January 1969, Giornale italiano delle malattie del torace,
T Midtvedt
January 1973, Scandinavian journal of respiratory diseases. Supplementum,
T Midtvedt
January 1975, Revista de igiena, bacteriologie, virusologie, parazitologie, epidemiologie, pneumoftiziologie. Pneumoftiziologia,
T Midtvedt
January 1973, Scandinavian journal of respiratory diseases. Supplementum,
T Midtvedt
November 1977, Die Medizinische Welt,
Copied contents to your clipboard!